Literature DB >> 7616262

Papillary craniopharyngioma: a clinicopathological study of 48 cases.

T B Crotty1, B W Scheithauer, W F Young, D H Davis, E G Shaw, G M Miller, P C Burger.   

Abstract

Two distinct clinicopathological variants of craniopharyngioma exist: the classic adamantinomatous type and a recently described papillary form that predominates in adults and reportedly behaves in a less aggressive manner. The present study describes the clinicopathological features of 48 patients with papillary craniopharyngioma treated at the Mayo Clinic between 1910 and 1994. An additional four tumors were found to have histological features of both adamantinomatous and papillary craniopharyngioma. Whereas adamantinomatous tumors typically occur in adolescent patients, the mean age of the 48 patients (23 males and 25 females) with papillary craniopharyngioma was 44.7 years (range 10 to 74 years). Presenting clinical features included visual impairment (84%), headache (68%), and pituitary insufficiency (anterior 42%; posterior 27%). Preoperative computerized tomography (CT) and magnetic resonance (MR) imaging in 17 patients typically revealed a noncalcified, partially cystic mass that enhanced peripherally and contained mural nodules (67%). Many (41%) of the lesions involved or extended into the third ventricle on imaging. At first surgery, gross total tumor removal was achieved in 17 patients (36%) and subtotal resection in 30 patients (64%) in whom tumor resection was attempted. Tumor recurrence was noted in two patients who underwent gross total removal. Tumor-free survival rates of 100% and 78% were obtained in patients who underwent gross total and subtotal resection at initial surgery, respectively. Postoperative radiation therapy was beneficial to patients having undergone a subtotal resection, with an increase in tumor-free survival from 26% to 86%. Aside from well-documented morphological distinctions, papillary craniopharyngiomas differ from adamantinomatous tumors in several important respects. These include the almost exclusive occurrence of papillary tumors in adulthood and their more uniform appearance on both CT and MR imaging. However, a preliminary analysis of our data suggests there are no significant differences between the two lesions with respect to resectability, efficacy of radiation therapy, and overall survival.

Entities:  

Mesh:

Year:  1995        PMID: 7616262     DOI: 10.3171/jns.1995.83.2.0206

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  46 in total

1.  Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.

Authors:  Shigeki Sekine; Tatsuhiro Shibata; Akiko Kokubu; Yukio Morishita; Masayuki Noguchi; Yukihiro Nakanishi; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Malignant transformation of craniopharyngioma: case report and review of the literature.

Authors:  Shuzi Gao; Xiangen Shi; Yanxia Wang; Hai Qian; Chengyin Liu
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

Review 3.  Radiotherapy of other sellar lesions.

Authors:  N Karavitaki
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 4.  Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging.

Authors:  Amit Mahajan; Richard A Bronen; Ali Y Mian; Sacit Bulent Omay; Dennis D Spencer; Silvio E Inzucchi
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

5.  Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.

Authors:  Prit Benny Malgulwar; Aruna Nambirajan; Pankaj Pathak; Mohammed Faruq; Vaishali Suri; Chitra Sarkar; Amandeep Jagdevan; Bhawani Shankar Sharma; Mehar Chand Sharma
Journal:  J Neurooncol       Date:  2017-05-12       Impact factor: 4.130

6.  Hypothalamus-referenced classification for craniopharyngiomas: evidence provided by the endoscopic endonasal approach.

Authors:  José M Pascual; Ruth Prieto; Ines Castro Dufourny; Ricardo Gil Simoes; Rodrigo Carrasco
Journal:  Neurosurg Rev       Date:  2012-12-16       Impact factor: 3.042

7.  Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.

Authors:  Brad E Zacharia; Samuel S Bruce; Hannah Goldstein; Hani R Malone; Alfred I Neugut; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2012-06-26       Impact factor: 12.300

8.  Acute presentation of craniopharyngioma in children and adults in a Danish national cohort.

Authors:  E H Nielsen; J O Jørgensen; P Bjerre; M Andersen; C Andersen; U Feldt-Rasmussen; L Poulsgaard; L Ø Kristensen; J Astrup; J Jørgensen; P Laurberg
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

9.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

10.  Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.

Authors:  Shannon Coy; Ziming Du; Shu-Hsien Sheu; Terri Woo; Fausto J Rodriguez; Mark W Kieran; Sandro Santagata
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.